Immatics N.V.

Last updated September 27, 2026
Favorite this organization

Organization details

Legal name
Immatics N.V.
Ownership
Public
Status
Active
SIC code
2836 — Biological Products, (No Diagnostic Substances)
Jurisdiction of incorporation
Netherlands
Headquarters city
Tubingen
Headquarters country
Germany
Fiscal year end
December
Ticker symbol
IMTX
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001809196

Board of directors

Follow this board

Chief executives

Jasuja Harpreet Singh · Chief Executive Officer
Since March 2026

Board connections

5 of this board's directors also sit on 12 other boards.

Network of Immatics N.V.'s board connections Freenome Inc. Freenome Inc. Solid Biosciences Inc. Solid Biosciences Inc. Adagio Medical Holdings Inc Adagio Medical Holding... Chubb Limited Chubb Limited Kardigan Inc. Kardigan Inc. LeonaBio Inc. LeonaBio Inc. MeiraGTx Holdings plc MeiraGTx Holdings plc Nautilus Biotechnology Inc. Nautilus Biotechnology... Protalix BioTherapeutics Inc. (DE) Protalix BioTherapeuti... Q32 Bio Inc. Q32 Bio Inc. Sana Biotechnology Inc. Sana Biotechnology Inc... Tectonic Therapeutic Inc. Tectonic Therapeutic I... Adam Leo Stone Adam Leo Stone Alise Reicin Alise Reicin Eliot Forster Eliot Forster Joseph Edelman Joseph Edelman Michael G. Atieh Michael G. Atieh Immatics N.V.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$7,499,991
1 purchase by 1 insider
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Aug 26, 2026 PERCEPTIVE ADVISORS LLC Director Open-market purchase +863,060 $8.69 $7,499,991

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.